Diamorphine
- Generic Name
- Diamorphine
- Brand Names
- -
- Drug Type
- Small Molecule
- Chemical Formula
- C21H23NO5
- CAS Number
- 561-27-3
- Unique Ingredient Identifier
- 70D95007SX
- Background
Diamorphine (heroin) is a narcotic analgesic that may be habit-forming. It is a controlled substance (opium derivative) listed in the U.S. Code of Federal Regulations, Title 21 Parts 329.1, 1308.11 (1987). Sale is forbidden in the United States by Federal statute. (Merck Index, 11th ed) Internationally, diamorphine is controlled under Schedules I and IV of the Single Convention on Narcotic Drugs. As heroin, it is illegal to manufacture, possess, or sell in the United States and the UK. However, under the name diamorphine, heroin is a legal prescription drug in the United Kingdom.
- Indication
Diamorphine, as a prescription medication in the United Kingdom, is indicated for use in the treatment of severe pain associated with surgical procedures, myocardial infarction or pain in the terminally ill and for the relief of dyspnoea in acute pulmonary edema .
- Associated Conditions
- -
- Associated Therapies
- -
Buprenorphine/Naloxone Treatment for Opioid Dependence-Experiment I(2) - 2
- Conditions
- Opioid-Related DisordersHeroin Dependence
- First Posted Date
- 1999-09-21
- Last Posted Date
- 2017-05-04
- Lead Sponsor
- University of Colorado, Denver
- Registration Number
- NCT00000327
- Locations
- 🇺🇸
University of Colorado Health Sciences Center, Denver, Colorado, United States
Buprenorphine/Naloxone Treatment for Opioid Dependence-Experiment 1 - 1
- Conditions
- Opioid-Related DisordersHeroin Dependence
- First Posted Date
- 1999-09-21
- Last Posted Date
- 2017-05-04
- Lead Sponsor
- University of Colorado, Denver
- Registration Number
- NCT00000326
- Locations
- 🇺🇸
University of Colorado Health Sciences Center, Denver, Colorado, United States
Drug Development Updates
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.